Science Explorer Interactive view Map
Company · Bethesda · United States

Pharmerit (United States)

In research, Pharmerit (United States) stands highest in Medicine (#10,160 of 17,978 worldwide) and Health Sciences (#12,522 of 20,462 worldwide), over all time.

World rank, all time
#27,850
of 42,892
Rank in United States
#5,974
of 8,685
Research works
260
▲ 7% vs 2013–17
Citations
3.7k
14.2 per fractional work
Top-10% rate
6.5%
record average 16.5%
Open access
42%
world 28%

What is Pharmerit (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #10,160 of 17,978 11.3%177
Health SciencesDomain #12,522 of 20,462 11.2%187

Each strip is that field’s whole ranked pool, with the notch where Pharmerit (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Materials Science: 2.69× its world share, 0 worksMaterials ScienceMedicine: 3.95× its world share, 3 worksMedicineDecision Sciences: 0.65× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.02× its world share, 0 worksEconomics, Econometr…Psychology: 1.64× its world share, 0 worksPsychologySocial Sciences: 0.54× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

Who are the top researchers at Pharmerit (United States)?

Ranked on the composite score, Marc Botteman, Jennifer Stephens and Sonya J. Snedecor lead among researchers whose main affiliation is Pharmerit (United States).

  1. 1 Marc Botteman United States · #375,499 worldwide 105 citations · 44 works
  2. 2 Jennifer Stephens United States · #625,179 worldwide 43 citations · 23 works
  3. 3 Sonya J. Snedecor United States · #840,080 worldwide 44 citations · 15 works
  4. 4 Ruchit Shah United States · #977,105 worldwide 25 citations · 22 works
  5. 5 Shelby Corman United States · #1,002,802 worldwide 29 citations · 20 works
  6. 6 Viktor Chirikov United States · #1,118,642 worldwide 14 citations · 19 works
  7. 7 Caitlyn T. Solem United States · #1,141,712 worldwide 16 citations · 17 works
All ranked researchers at Pharmerit (United States)

Which keywords describe research at Pharmerit (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Prognostic Factors, Immunotherapy, Cost-effectiveness Analysis, Health Utility Measures, Diagnosis and Rituximab.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology42▲ 4.0×66 topics
  2. Quality of Life19▲ 5.5×13 topics
  3. Diagnosis13▲ 5.1×17 topics
  4. Prognostic Factors13▲ 11×9 topics
  5. Immunotherapy12▲ 7.3×15 topics
  6. Cost-effectiveness Analysis12▲ 57×1 topic
  7. Health Utility Measures12▲ 57×1 topic
  8. Management11▲ 5.3×11 topics
  9. Clinical Trials10▲ 6.5×13 topics
  10. Treatment10▲ 3.1×19 topics
  11. Rituximab10▲ 25×2 topics
  12. Clinical Practice Guidelines10▲ 6.8×10 topics
  13. Cost of Care8▲ 165×1 topic
  14. Financial Toxicity8▲ 165×1 topic
  15. Biomarkers8▲ 4.8×11 topics
  16. Global Burden8▲ 5.4×9 topics
  17. Prostate Cancer8▲ 19×4 topics
  18. Virulence Factors7▲ 15×4 topics
  19. Antimicrobial Resistance7▲ 10×4 topics
  20. Cancer Treatment7▲ 10×4 topics
  21. Clinical Management7▲ 12×4 topics
  22. Guidelines7▲ 5.3×10 topics
  23. Therapeutic Targets6▲ 11×2 topics
  24. Antiretroviral Therapy6▲ 11×6 topics
  25. Chronic Lymphocytic Leukemia6▲ 50×1 topic
  26. Genomic Aberrations6▲ 50×1 topic
  27. PET Imaging6▲ 11×4 topics
  28. Healthcare-Associated Infections6▲ 19×5 topics
  29. Targeted Therapy6▲ 11×4 topics
  30. Cancer Incidence6▲ 15×4 topics
  31. Prophylaxis6▲ 15×3 topics
  32. Breast Cancer6▲ 7.5×6 topics
  33. Lymphoma5▲ 14×3 topics
  34. Staphylococcus aureus5▲ 27×2 topics
  35. Genomic Profiling5▲ 20×2 topics
  36. Population-Based Study5▲ 33×2 topics
  37. Gene Expression Profiling5▲ 19×2 topics
  38. Inhibitors5▲ 26×2 topics
  39. Molecular Profiling5▲ 16×2 topics
  40. Recombinant Factor VIIa5▲ 45×2 topics

Which research topics does Pharmerit (United States) publish most on?

By volume in 2022–2025: Myasthenia Gravis and Thymoma, Systemic Lupus Erythematosus Research, Advanced Cellulose Research Studies and Blood groups and transfusion.

  1. 1 Myasthenia Gravis and Thymoma Neurology 1 works
  2. 2 Systemic Lupus Erythematosus Research Rheumatology 0 works
  3. 3 Advanced Cellulose Research Studies Biomaterials 0 works
  4. 4 Blood groups and transfusion Hematology 0 works
  5. 5 Hemoglobinopathies and Related Disorders Genetics 0 works
  6. 6 Iron Metabolism and Disorders Hematology 0 works
  7. 7 Innovative Teaching and Learning Methods Developmental and Educational Psychology 0 works
  8. 8 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  9. 9 Science Education and Pedagogy Education 0 works
  10. 10 HIV-related health complications and treatments Emergency Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.3%not open57.7%

World: 28% of research is openly available.

with international co-authors32.4%domestic only67.6%

World: 19% is written across borders.

How has Pharmerit (United States)'s research output changed?

Output in 2018–2022 was 7% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Bethesda

All research institutions in Bethesda

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.